BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 13344290)

  • 21. The relation of various variables to the hypoglycemic action of 1-butyl-3-p-tolylsulfonylurea in patients with diabetes mellitus.
    DIENGOTT D; DOLGER H; MIRSKY IA
    Metabolism; 1956 Nov; 5(6 Part 2):875-93. PubMed ID: 13378057
    [No Abstract]   [Full Text] [Related]  

  • 22. [Critical study of the mechanism of action of the oral anti-diabetic agent, nadisan].
    FRAENKEL KA; SCHULZ K
    Dtsch Med J; 1956 Apr; 7(8):209-14. PubMed ID: 13344175
    [No Abstract]   [Full Text] [Related]  

  • 23. Trial of an oral hypoglycaemic agent in diabetes.
    WOLFF FW; STEWART GA; CROWLEY MF; BLOOM A
    Br Med J; 1956 Aug; 2(4990):440-5. PubMed ID: 13342508
    [No Abstract]   [Full Text] [Related]  

  • 24. Recent studies relative to the treatment of diabetes; special reference to new oral antidiabetic drugs.
    WILLIAMS RH; HENLEY ED
    AMA Arch Intern Med; 1957 Apr; 99(4):501-18. PubMed ID: 13410156
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical trial of the new oral hypoglycaemic agent BZ 55.
    HUNT JA; OAKLEY W; LAWRENCE RD
    Br Med J; 1956 Aug; 2(4990):445-8. PubMed ID: 13342509
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical experiences with carbutamide, an orally given hypoglycemic agent; preliminary report.
    RIDOLFO AS; KIRTLEY WR
    J Am Med Assoc; 1956 Apr; 160(15):1285-8. PubMed ID: 13306540
    [No Abstract]   [Full Text] [Related]  

  • 27. [Oral treatment of diabetes mellitus with D-860, a new hypoglycemic but not sulfonamidic drug; clinical study of 90 cases].
    INTROZZI P; MARIGO S
    Prog Med (Napoli); 1956 Sep; 12(17):513-27. PubMed ID: 13379550
    [No Abstract]   [Full Text] [Related]  

  • 28. Progress report of American Diabetes Association on orally effective hypoglycemic sulfonylureas.
    COLWELL AR; INGLE D; KRAHL ME; LEVINE R; RICKETTS HT
    J Am Med Assoc; 1956 Nov; 162(10):976-7. PubMed ID: 13366694
    [No Abstract]   [Full Text] [Related]  

  • 29. [A brief contribution on cutaneous side effects of the oral antidiabetic remedy BZ 55 (nadisan)].
    WALTHER H; WALZ H
    Ther Ggw; 1956 May; 95(5):183-4. PubMed ID: 13352317
    [No Abstract]   [Full Text] [Related]  

  • 30. CURRENT investigation of the hypoglycemic action of sulfonylureas.
    Nutr Rev; 1957 May; 15(5):150-1. PubMed ID: 13431090
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment for diabetes with sulfamide hypoglycemic agents].
    DEUIL R
    Rev Prat; 1956 Dec; 6(33):3687-94. PubMed ID: 13408836
    [No Abstract]   [Full Text] [Related]  

  • 32. Hypoglycaemic sulphonamides in the management of diabetes mellitus.
    DOWNIE E; BORNSTEIN J; HUDSON B
    Australas Ann Med; 1957 May; 6(2):105-12. PubMed ID: 13445634
    [No Abstract]   [Full Text] [Related]  

  • 33. [Sulfamides, hypoglycaemic and antidiabetic].
    Thomas J
    Rev Prat; 1956 May; 6(14):1548-54. PubMed ID: 13336923
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical studies on the hypoglycaemic action of the sulphonylureas.
    BUTTERFIELD WJ; CAMP JL; HARDWICK C; HOLLING HE
    Lancet; 1957 Apr; 272(6972):753-6. PubMed ID: 13417585
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical tests of the antidiabetic sulfa drugs.
    EICHBAUM FW
    Rev Bras Med; 1957 Jan; 14(1):5-11. PubMed ID: 13442028
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of aged diabetics with hypoglycemic sulfonamides].
    DEMOL O; MAHAUX J
    Acta Clin Belg; 1956; 11(3):275-98. PubMed ID: 13339058
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical experience with hypoglycemic sulfonamides.
    CAMPOS PC; NAMIN EP
    J Philipp Med Assoc; 1957 May; 33(5):359-68. PubMed ID: 13439554
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of diabetes mellitus with hypoglycemic sulfonamides].
    BOULIN R
    Gaz Med Fr; 1957 Mar; 64(6):545-53. PubMed ID: 13427960
    [No Abstract]   [Full Text] [Related]  

  • 39. Hypoglycemic effects of 1-butyl-3-p-toluene sulfonylurea given orally in human diabetic subjects; a preliminary report.
    MILLER M; CRAIG JW
    Metabolism; 1956 Mar; 5(2):162-4. PubMed ID: 13296878
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of sulphonylurea derivatives in the management of diabetes mellitus; a preliminary report.
    DOWNIE E; BORNSTEIN J; HUDSON B; TAYLOR K
    Med J Aust; 1956 Jun; 43(26):1072-8. PubMed ID: 13347438
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.